TOXICOLOGICAL PROFILE for SILVER Agency for Toxic
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Dermatology Eponyms – Sign –Lexicon (P)
2XU'HUPDWRORJ\2QOLQH Historical Article Dermatology Eponyms – sign –Lexicon (P)� Part 2 Piotr Brzezin´ ski1,2, Masaru Tanaka3, Husein Husein-ElAhmed4, Marco Castori5, Fatou Barro/Traoré6, Satish Kashiram Punshi7, Anca Chiriac8,9 1Department of Dermatology, 6th Military Support Unit, Ustka, Poland, 2Institute of Biology and Environmental Protection, Department of Cosmetology, Pomeranian Academy, Slupsk, Poland, 3Department of Dermatology, Tokyo Women’s Medical University Medical Center East, Tokyo, Japan, 4Department of Dermatology, San Cecilio University Hospital, Granada, Spain, 5Medical Genetics, Department of Experimental Medicine, Sapienza - University of Rome, San Camillo-Forlanini Hospital, Rome, Italy, 6Department of Dermatology-Venerology, Yalgado Ouédraogo Teaching Hospital Center (CHU-YO), Ouagadougou, Burkina Faso, 7Consultant in Skin Dieseases, VD, Leprosy & Leucoderma, Rajkamal Chowk, Amravati – 444 601, India, 8Department of Dermatology, Nicolina Medical Center, Iasi, Romania, 9Department of Dermato-Physiology, Apollonia University Iasi, Strada Muzicii nr 2, Iasi-700399, Romania Corresponding author: Piotr Brzezin′ski, MD PhD, E-mail: [email protected] ABSTRACT Eponyms are used almost daily in the clinical practice of dermatology. And yet, information about the person behind the eponyms is difficult to find. Indeed, who is? What is this person’s nationality? Is this person alive or dead? How can one find the paper in which this person first described the disease? Eponyms are used to describe not only disease, but also clinical signs, surgical procedures, staining techniques, pharmacological formulations, and even pieces of equipment. In this article we present the symptoms starting with (P) and other. The symptoms and their synonyms, and those who have described this symptom or phenomenon. Key words: Eponyms; Skin diseases; Sign; Phenomenon Port-Light Nose sign or tylosis palmoplantaris is widely related with the onset of squamous cell carcinoma of the esophagus. -
Guide to Policy & Practice Questions
OREGON BOARD OF CHIROPRACTIC EXAMINERS GUIDE TO POLICY & PRACTICE QUESTIONS 530 Center St NE, suite 620 Salem, OR 97301 (503) 378-5816 [email protected] Updated/Adopted: 9/17/2020 TABLE OF CONTENTS SECTION I ............................................................................................................................................................................................... 6 DEVICES, PROCEDURES, AND SUBSTANCES ............................................................................................................................... 6 DEVICES ................................................................................................................................................................ 6 BAX 3000 AND SIMILAR DEVICES................................................................................................................................................ 6 BIOPTRON LIGHT THERAPY ........................................................................................................................................................ 6 CPAP MACHINE, ORDERING ....................................................................................................................................................... 6 CTD MARK I MULTI-TORSION TRACTION DEVICE................................................................................................................... 6 DYNATRON 2000 ........................................................................................................................................................................... -
Clinicopathological Correlation of Acquired Hyperpigmentary Disorders
Symposium Clinicopathological correlation of acquired Dermatopathology hyperpigmentary disorders Anisha B. Patel, Raj Kubba1, Asha Kubba1 Department of Dermatology, ABSTRACT Oregon Health Sciences University, Portland, Oregon, Acquired pigmentary disorders are group of heterogenous entities that share single, most USA, 1Delhi Dermatology Group, Delhi Dermpath significant, clinical feature, that is, dyspigmentation. Asians and Indians, in particular, are mostly Laboratory, New Delhi, India affected. Although the classic morphologies and common treatment options of these conditions have been reviewed in the global dermatology literature, the value of histpathological evaluation Address for correspondence: has not been thoroughly explored. The importance of accurate diagnosis is emphasized here as Dr. Asha Kubba, the underlying diseases have varying etiologies that need to be addressed in order to effectively 10, Aradhana Enclave, treat the dyspigmentation. In this review, we describe and discuss the utility of histology in the R.K. Puram, Sector‑13, diagnostic work of hyperpigmentary disorders, and how, in many cases, it can lead to targeted New Delhi ‑ 110 066, India. E‑mail: and more effective therapy. We focus on the most common acquired pigmentary disorders [email protected] seen in Indian patients as well as a few uncommon diseases with distinctive histological traits. Facial melanoses, including mimickers of melasma, are thoroughly explored. These diseases include lichen planus pigmentosus, discoid lupus erythematosus, drug‑induced melanoses, hyperpigmentation due to exogenous substances, acanthosis nigricans, and macular amyloidosis. Key words: Facial melanoses, histology of hyperpigmentary disorders and melasma, pigmentary disorders INTRODUCTION focus on the most common acquired hyperpigmentary disorders seen in Indian patients as well as a few Acquired pigmentary disorders are found all over the uncommon diseases with distinctive histological traits. -
Safety Data Sheet According to 1907/2006/EC, Article 31 Printing Date 17.04.2015 Version Number 2 Revision: 17.04.2015
Page 1/10 Safety data sheet according to 1907/2006/EC, Article 31 Printing date 17.04.2015 Version number 2 Revision: 17.04.2015 * SECTION 1: Identification of the substance/mixture and of the company/undertaking · 1.1 Product identifier · Trade name: Arcuplat Schnellversilberung m. 30g Ag/l Arcuplat silver bath with 30 g Ag/l · 1.2 Relevant identified uses of the substance or mixture and uses advised against No further relevant information available. · Application of the substance / the mixture Galvanic bath · 1.3 Details of the supplier of the safety data sheet · Manufacturer/Supplier: Wieland Dental + Technik GmbH & Co. KG Lindenstr. 2 75175 Pforzheim Telefon +49 (0) 7231-37050, Telefax +49 (0) 7231-357959 · Further information obtainable from: [email protected] · 1.4 Emergency telephone number: GIZ-Nord, Göttingen, Germany +49 551 19240 Member of EPECS Network * SECTION 2: Hazards identification · 2.1 Classification of the substance or mixture · Classification according to Regulation (EC) No 1272/2008 GHS06 skull and crossbones Acute Tox. 2 H300 Fatal if swallowed. Acute Tox. 1 H310 Fatal in contact with skin. Acute Tox. 3 H331 Toxic if inhaled. GHS05 corrosion Skin Corr. 1C H314 Causes severe skin burns and eye damage. GHS09 environment Aquatic Chronic 2 H411 Toxic to aquatic life with long lasting effects. · Classification according to Directive 67/548/EEC or Directive 1999/45/EC T+; Very toxic R26/27/28: Very toxic by inhalation, in contact with skin and if swallowed. C; Corrosive R34: Causes burns. N; Dangerous for the environment R51/53: Toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment. -
Multi-Organ Teratogenesis Sequels of Bigger Size Particles Colloidal
ytology & f C H o is Prakash, et al., J Cytol Histol 2018, 9:2 l t a o n l o r DOI: 10.4172/2157-7099.1000501 g u y o J Journal of Cytology & Histology ISSN: 2157-7099 Research Article Open Access Multi-Organ Teratogenesis Sequels of Bigger Size Particles Colloidal Silver in Primate Vertebrates Pani Jyoti Prakash*1, Singh Royana2 and Pani Sankarsan3 1Department of Anatomy, Faculty of Medicine, Institute of Medical Science and Research, Karjat, Bhivpuri, India 2Department of Anatomy, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttarpradesh, India 3Deapartment of Surgery, Institute of Medical Science and Research, Karjat, Bhivpuri, India *Corresponding author: Prakash PJ, Department of Anatomy, Faculty of Medicine, Institute of Medical Science and Research, Karjat, Bhivpuri, India, Tel: 8433668356; E-mail: [email protected] Received date: February 21, 2018; Accepted date: March 12, 2018; Published date: March 16, 2018 Copyright: © 2018 Prakash PJ, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Back ground: In this most recent, update global arena for consumers products most of the daily applications of bigger silver nano particles (20 to 100 nano meter range) are effected as anti-viral and anti-parasitic agents in clinical medicine and diagnosis which is a positive feedback. However, the major negative feedback of bigger size silver nano particles on human, animal and primate vertebrate body is multisystem teratogenicity focuses. Material and methods: This study was designed to investigate teratogenic effects of bigger size nano silver which is poly vinyl pyrollidone coated and sodium borohydride stabilized. -
Orthomolecular Psychiatry & RANZCP
SENATE SELECT COMMITTEE ON MENTAL HEALTH INQUIRY SUBMISSION of Douglas L. McIver ATTACHMENT B Background: Orthomolecular Psychiatry & RANZCP The full text of RANZCP Position Statement #24, titled “Orthomolecular Psychiatry”, is available on the RANZCP website <www.ranzcp.org> in pdf format <http://www.ranzcp.org/publicarea/posstate.asp>. +++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ There has been much controversy surrounding the issues which led to the formulation of a statement by the RANZCP General Council. The catalyst for the issues was in the context of the Medicare Benefits Schedule when rebates were sought in 1980 by clients of Dr Chris Reading BSc., Dip. Ag.Sc., M.B., B.S., F.R.A.N.Z.C.P. (a Sydney physician and psychiatrist) for some pathology screening tests requested by Dr Reading. Issues arose about orthomolecular medicine and orthomolecular psychiatry in the context of the requirement for the pathology screening tests requested. Issues about the screening tests and orthomolecular psychiatry were raised in Federal Parliament between 1982-84. Note, for instance, the House of Representatives (HoR) Hansard, 18 August 1982 (p550), Answer to Question No 4112; HoR Hansard, 6 March 1984 (pp600/601), Answer to Question 387; Senate Hansard, 22 October 1984 (2099/2100), Questions without Notice, ‘Orthomolecular Medicine’; Senate Hansard 24 October 1984 (p2286), Speech by Senator Haines in debate on Appropriation (Parliamentary Departments) Bill. I encourage the Select Committee to inform themselves of a seven page document prepared by the SOMA Health Association of Australia Ltd titled ‘The saga of the altered definition of orthomolecular psychiatry and the consequences which ensued therefrom’. SOMA Health <http://www.soma-health.com.au> is an independent body and all work is voluntary. -
Chelation Therapy
Corporate Medical Policy Chelation Therapy File Name: chelation_therapy Origination: 12/1995 Last CAP Review: 2/2021 Next CAP Review: 2/2022 Last Review: 2/2021 Description of Procedure or Service Chelation therapy is an established treatment for the removal of metal toxins by converting them to a chemically inert form that can be excreted in the urine. Chelation therapy comprises intravenous or oral administration of chelating agents that remove metal ions such as lead, aluminum, mercury, arsenic, zinc, iron, copper, and calcium from the body. Specific chelating agents are used for particular heavy metal toxicities. For example, desferroxamine (not Food and Drug Administration [FDA] approved) is used for patients with iron toxicity, and calcium-ethylenediaminetetraacetic acid (EDTA) is used for patients with lead poisoning. Note that disodium-EDTA is not recommended for acute lead poisoning due to the increased risk of death from hypocalcemia. Another class of chelating agents, called metal protein attenuating compounds (MPACs), is under investigation for the treatment of Alzheimer’s disease, which is associated with the disequilibrium of cerebral metals. Unlike traditional systemic chelators that bind and remove metals from tissues systemically, MPACs have subtle effects on metal homeostasis and abnormal metal interactions. In animal models of Alzheimer’s disease, they promote the solubilization and clearance of β-amyloid protein by binding to its metal-ion complex and also inhibit redox reactions that generate neurotoxic free radicals. MPACs therefore interrupt two putative pathogenic processes of Alzheimer’s disease. However, no MPACs have received FDA approval for treating Alzheimer’s disease. Chelation therapy has also been investigated as a treatment for other indications including atherosclerosis and autism spectrum disorder. -
Nickel Interim Final
Ecological Soil Screening Levels for Nickel Interim Final OSWER Directive 9285.7-76 U.S. Environmental Protection Agency Office of Solid Waste and Emergency Response 1200 Pennsylvania Avenue, N.W. Washington, DC 20460 March 2007 This page intentionally left blank TABLE OF CONTENTS 1.0 INTRODUCTION .......................................................1 2.0 SUMMARY OF ECO-SSLs FOR NICKEL...................................1 3.0 ECO-SSL FOR TERRESTRIAL PLANTS....................................3 4.0 ECO-SSL FOR SOIL INVERTEBRATES....................................6 5.0 ECO-SSL FOR AVIAN WILDLIFE.........................................6 5.1 Avian TRV ........................................................6 5.2 Estimation of Dose and Calculation of the Eco-SSL .......................10 6.0 ECO-SSL FOR MAMMALIAN WILDLIFE .................................10 6.1 Mammalian TRV ..................................................10 6.2 Estimation of Dose and Calculation of the Eco-SSL .......................14 7.0 REFERENCES .........................................................16 7.1 General Nickel References ..........................................16 7.2 References for Plants and Soil Invertebrates .............................16 7.3 References Rejected for Use in Deriving Plant and Soil Invertebrate Eco-SSLs ...............................................................18 7.4 References Used in Deriving Wildlife TRVs ............................34 7.5 References Rejected for Use in Derivation of Wildlife TRV ................38 i LIST -
Chemical List
1 EXHIBIT 1 2 CHEMICAL CLASSIFICATION LIST 3 4 1. Pyrophoric Chemicals 5 1.1. Aluminum alkyls: R3Al, R2AlCl, RAlCl2 6 Examples: Et3Al, Et2AlCl, EtAlCl2, Me3Al, Diethylethoxyaluminium 7 1.2. Grignard Reagents: RMgX (R=alkyl, aryl, vinyl X=halogen) 8 1.3. Lithium Reagents: RLi (R = alkyls, aryls, vinyls) 9 Examples: Butyllithium, Isobutyllithium, sec-Butyllithium, tert-Butyllithium, 10 Ethyllithium, Isopropyllithium, Methyllithium, (Trimethylsilyl)methyllithium, 11 Phenyllithium, 2-Thienyllithium, Vinyllithium, Lithium acetylide ethylenediamine 12 complex, Lithium (trimethylsilyl)acetylide, Lithium phenylacetylide 13 1.4. Zinc Alkyl Reagents: RZnX, R2Zn 14 Examples: Et2Zn 15 1.5. Metal carbonyls: Lithium carbonyl, Nickel tetracarbonyl, Dicobalt octacarbonyl 16 1.6. Metal powders (finely divided): Bismuth, Calcium, Cobalt, Hafnium, Iron, 17 Magnesium, Titanium, Uranium, Zinc, Zirconium 18 1.7. Low Valent Metals: Titanium dichloride 19 1.8. Metal hydrides: Potassium Hydride, Sodium hydride, Lithium Aluminum Hydride, 20 Diethylaluminium hydride, Diisobutylaluminum hydride 21 1.9. Nonmetal hydrides: Arsine, Boranes, Diethylarsine, diethylphosphine, Germane, 22 Phosphine, phenylphosphine, Silane, Methanetellurol (CH3TeH) 23 1.10. Non-metal alkyls: R3B, R3P, R3As; Tributylphosphine, Dichloro(methyl)silane 24 1.11. Used hydrogenation catalysts: Raney nickel, Palladium, Platinum 25 1.12. Activated Copper fuel cell catalysts, e.g. Cu/ZnO/Al2O3 26 1.13. Finely Divided Sulfides: Iron Sulfides (FeS, FeS2, Fe3S4), and Potassium Sulfide 27 (K2S) 28 REFERRAL -
CHAPTER E49 Heavy Metal Poisoning
discussion with respect to the four most hazardous toxicants (arsenic, CHAPTER e49 cadmium, lead, and mercury). Arsenic, even at moderate levels of exposure, has been clearly linked with increased risks for cancer at a number of different tissue Heavy Metal Poisoning sites. These risks appear to be modified by smoking, folate and selenium status, and other factors. Evidence is also emerging that low-level arsenic may cause neurodevelopmental delays in children Howard Hu and possibly diabetes, but the evidence (particularly for diabetes) remains uneven. Metals pose a significant threat to health through low-level environ- Serious cadmium poisoning from the contamination of food mental as well as occupational exposures. One indication of their and water by mining effluents in Japan contributed to the 1946 CHAPTER e49 importance relative to other potential hazards is their ranking by outbreak of “itai-itai” (“ouch-ouch”) disease, so named because the U.S. Agency for Toxic Substances and Disease Registry, which of cadmium-induced bone toxicity that led to painful bone frac- maintains an updated list of all hazards present in toxic waste sites tures. Modest exposures from environmental contamination have according to their prevalence and the severity of their toxicity. The recently been associated in some studies with a lower bone density, first, second, third, and seventh hazards on the list are heavy metals: a higher incidence of fractures, and a faster decline in height in lead, mercury, arsenic, and cadmium, respectively (http://www. both men and women, effects that may be related to cadmium’s atsdr.cdc.gov/cercla/07list.html) . Specific information pertaining calciuric effect on the kidney. -
A Preliminary Risk-Based Screening Approach for Air Toxics Monitoring Data Sets U.S
A Preliminary Risk-Based Screening Approach for Air Toxics Monitoring Data Sets U.S. Environmental Protection Agency Air, Pesticides, and Toxics Management Division Atlanta, Georgia 30303 EPA-904-B-06-001 www.epa.gov/region4/air/airtoxic/ October 2010 Cover Photo: Greg Noah/EPA (Version 2) Disclaimer The information and procedures set forth here are intended as a technical resource to those conducting risk-based evaluations of air toxics monitoring data. This document does not constitute rulemaking by the Agency, and cannot be relied on to create a substantive or procedural right enforceable by any party in litigation with the United States. As indicated by the use of non-mandatory language such as “may” and “should,” it provides recommendations and does not impose any legally binding requirements. In the event of a conflict between the discussion in this document and any Federal statute or regulation, this document would not be controlling. The general description provided here may not apply to a particular situation based upon the circumstances. Interested parties are free to raise questions and objections about the substance of this methodology and the appropriateness of its application to a particular situation. EPA Region 4 and other decision makers retain the discretion to adopt approaches on a case-by-case basis that differ from those described in this document where appropriate. EPA Region 4 may take action that is at variance with the recommendations and procedures in this document and may change them at any time without public notice. This is a living document and may be revised periodically. EPA Region 4 welcomes public input on this document at any time. -
Effect of Toxic Metals on Human Health
94 The Open Nutraceuticals Journal, 2010, 3, 94-99 Open Access Effect of Toxic Metals on Human Health Varsha Mudgal1, Nidhi Madaan1, Anurag Mudgal2, R.B. Singh3 and Sanjay Mishra1,4,* 1Department of Biotechnology and Microbiology, Institute of Foreign Trade & Management, Delhi Road, Moradabad 244 001, UP, India 2Department of Mechanical Engineering, College of Engineering and Technology, IFTM Campus, Moradabad, 244 001, UP, India 3Halberg Hospital & Research Center, Civil Lines, Moradabad 244 001, UP, India 4Department of Biotechnology, College of Engineering & Technology, IFTM Campus, Moradabad 244 001, UP, India Abstract: Metal ions such as iron and copper are among the key nutrients that must be provided by dietary sources. In developing countries, there is an enormous contribution of human activities to the release of toxic chemicals, metals and metalloids into the atmosphere. These toxic metals are accumulated in the dietary articles of man. Numerous foodstuffs have been evaluated for their contributions to the recommended daily allowance both to guide for satisfactory intake and also to prevent over exposure. Further, food chain polluted with toxic metals and metalloids is an important route of hu- man exposure and may cause several dangerous effects on human. In this review we summarized effects of various toxic metals on human health. Keywords: Bioavailability, Contamination, Heavy metals, Human health, Metal toxicity. INTRODUCTION For the maintenance of health, a great deal of preventa- tive measures is in place to avoid ingestion of potentially There are around thirty chemical elements that play a toxic metal ions. From monitoring endogenous levels of pivotal role in various biochemical and physiological metal ions in foods and drinks to detecting contamination mechanisms in living organisms, and recognized as essential during food preparation, European countries spend signifi- elements for life.